Metformin use in people with diabetes was linked to a significantly lower risk of developing intermediate age-related macular degeneration.
Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855), a global, commercial stage, integrated biopharmaceutical company engaged in the discovery, development and commercialization of novel, ...
A 2026 company-issued informational report covering NatureGlyco's product descriptions, ingredient references, pricing, ...
Orum Therapeutics (“Orum” or the “Company”) (KRX: 475830), a biotechnology company pioneering the field of degrader antibody conjugates (DACs), today announced that new preclinical data on ORM-1153, a ...
Throughout the year, the Company reported significant positive preclinical findings for SIL204 across eight KRAS mutations and four cancer types, including first evidence of activity in gastric cancer ...
A large meta-analysis of 50 cohort studies involving over three million adults found that higher consumption of certain ...
Revolution Medicines, Inc. (Nasdaq:RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced that nine oral and poster ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results